C. Crowley

Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.

Madeleine Duvic, Ángel G. Martín, Y. Kim et al. · PubMed · 2001 · 438 citations

Medicine, Pharmacology, Pharmacotherapy +14

Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial

Peter Heald, Marilyn A. Mehlmauer, Ann Martin et al. · Journal of the American Academy of Dermatology · 2003 · 161 citations

Medicine, Dermatology, Oncology +11

2009 SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON α2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS

E. Läwitz, M. Rodriquez-Torres, Vinod K. Rustgi et al. · Journal of Hepatology · 2010 · 41 citations

Medicine, Infectious Diseases, Pharmacotherapy +9

1055 ANTIVIRAL ACTIVITY OF ANA598, A POTENT NON- NUCLEOSIDE POLYMERASE INHIBITOR, IN CHRONIC HEPATITIS C PATIENTS

Eric Lawitz, M. Rodríguez‐Torres, Michael DeMicco et al. · Journal of Hepatology · 2009 · 39 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Pharmacokinetics and Pharmacodynamics of Setrobuvir, an Orally Administered Hepatitis C Virus Non-Nucleoside Analogue Inhibitor

Navita L. Mallalieu, Mohamad H. Rahimy, C. Crowley et al. · Clinical Therapeutics · 2014 · 10 citations

Medicine, Pharmacokinetics, Pharmacology +10